Entresto (Sacubitril/Valsartan) is a prescription drug approved by the FDA to reduce the risk of hospitalization and death in people with chronic heart failure and reduced ejection fraction. Here are some key points:

- Composition: Combination of Sacubitril (a neprilysin inhibitor) and Valsartan (an angiotensin II receptor Show Full Answer

Entresto (Sacubitril/Valsartan) is a prescription drug approved by the FDA to reduce the risk of hospitalization and death in people with chronic heart failure and reduced ejection fraction. Here are some key points:

- Composition: Combination of Sacubitril (a neprilysin inhibitor) and Valsartan (an angiotensin II receptor blocker).
- Mechanism:
- Sacubitril increases levels of substances that protect the vascular system.
- Valsartan relaxes blood vessels.
- Dosage: Taken twice daily in tablet form.
- Common Side Effects: Cough, dizziness, low blood pressure, electrolyte imbalance, and kidney failure.
- Serious Side Effects: Angioedema (severe swelling), impaired kidney function, and fetal toxicity.

For more details, you can visit the [Entresto page on MyHeartDiseaseTeam](https://www.MyHeartDiseaseTeam.com/treatments/e...).

 This AI-generated response comes from MyHeartDiseaseTeam and other selected sources. It is not a substitute for medical advice. Always ask your doctor about specific health concerns.

Entresto (Sacubitril/Valsartan) for Heart Disease | MyHeartDiseaseTeam

Teveten (Eprosartan) for Heart Disease | MyHeartDiseaseTeam